384 related articles for article (PubMed ID: 16494512)
1. ACE inhibitors in pediatric patients with heart failure.
Momma K
Paediatr Drugs; 2006; 8(1):55-69. PubMed ID: 16494512
[TBL] [Abstract][Full Text] [Related]
2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors and moderate hypertension.
McAreavey D; Robertson JI
Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. [Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results].
Wessel A; Buchhorn R; Bürsch J
Klin Padiatr; 2000; 212(2):53-9. PubMed ID: 10812553
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors in heart failure: an update.
Smith WH; Ball SG
Basic Res Cardiol; 2000; 95 Suppl 1():I8-14. PubMed ID: 11192359
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors: a comparative review.
Raia JJ; Barone JA; Byerly WG; Lacy CR
DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
9. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
Langtry HD; Markham A
Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
[TBL] [Abstract][Full Text] [Related]
10. Congestive heart failure: what should be the initial therapy and why?
Chatterjee K
Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
Song JC; White CM
Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
[TBL] [Abstract][Full Text] [Related]
12. The management of heart failure--an overview.
Erdmann E
Basic Res Cardiol; 2000; 95 Suppl 1():I3-7. PubMed ID: 11192349
[TBL] [Abstract][Full Text] [Related]
13. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
Pisacane C; Pacileo G; Santoro G; Sarubbi B; Iacono C; Russo MG; Calabrò R
Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors in heart failure: prospects and limitations.
Pitt B
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():285-90. PubMed ID: 9211022
[TBL] [Abstract][Full Text] [Related]
16. Medical management of chronic heart failure in children.
Ross RD
Am J Cardiovasc Drugs; 2001; 1(1):37-44. PubMed ID: 14728050
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitors in the treatment of heart failure.
DiBianco R
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII32-8. PubMed ID: 2189619
[TBL] [Abstract][Full Text] [Related]
18. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
Dékány M; Bányai F; Antalóczy Z
Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
